Ventorp F, Bay-Richter C, Nagendra AS, Janelidze S, Matsson VS, Lipton J, et al
Although no routine laboratory monitoring is required with GLP-1s, Bordone recommended periodically rechecking relevant lab tests because improvements on these measures can encourage patients taking GLP-1s
Limitations This consensus reflects the views of a multidisciplinary expert panel in Kuwait but was not based on a formal Delphi process or structured stakeholder engagement, such as patient or caregiver input
The agency has seized packages of misbranded medication on multiple occasions over the past couple of years and even indicted the people behind the illegal transactions
Whatever about some of this being counterfeit product, more must be done by drug producers and regulators to ensure that whatever limited stock has been produced is getting to pharmacies, so that only patients with prescriptions can access it, for legitimate medical reasons
doi: Liss D, Cherupally M, OBrien M, et al